What it's for (Indications)
- Dimehydrinate is primarily indicated for the prevention and treatment of nausea, vomiting, and dizziness associated with motion sickness.
- It is effective in mitigating symptoms such as general queasiness, stomach upset, and vertigo caused by travel in vehicles, boats, or aircraft.
- Additionally, it may be utilized for managing symptoms of other vestibular disorders that manifest with similar issues, offering relief from the unpleasant sensations arising from disturbances in balance.
- Its therapeutic efficacy stems from its action on the central nervous system, providing symptomatic relief for various forms of kinetosis, by influencing the chemoreceptor trigger zone and vestibular apparatus.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | For adults and children 12 years of age and older, the recommended oral dosage is typically 50 to 100 mg every 4 to 6 hours as needed. The total dosage should not exceed 400 mg within a 24-hour period. For children aged 6 to 11 years, a usual dose ranges from 25 to 50 mg every 6 to 8 hours, with a maximum of 150 mg in 24 hours. For children aged 2 to 5 years, the typical dose is 12.5 to 25 mg every 6 to 8 hours, not exceeding 75 mg in 24 hours. It is crucial to administer the first dose approximately 30 to 60 minutes before anticipated exposure to motion to ensure optimal prophylactic effect. Dosage adjustments may be necessary for elderly patients or those with hepatic or renal impairment, and should be made under strict medical supervision. Always follow the specific instructions provided by a healthcare professional or the product labeling. |
Safety & Warnings
Common Side Effects
- Common adverse effects associated with dimehydrinate predominantly include central nervous system depression manifestations such as drowsiness, sedation, dizziness, and impaired coordination, which can significantly affect daily activities requiring mental alertness.
- Other frequent anticholinergic effects comprise dry mouth, blurred vision, urinary retention (especially in men with prostatic hypertrophy), and constipation, which can be particularly bothersome in predisposed individuals.
- Less common but potentially serious side effects include paradoxical excitation (especially in children), palpitations, tachycardia, hypotension, headache, nervousness, and, rarely, convulsions or seizures, particularly with overdose.
- Elderly patients are at an increased risk for confusion, disorientation, cognitive impairment, and falls due to pronounced anticholinergic effects and increased sensitivity.
- Patients should be advised to avoid activities requiring full mental acuity until they understand how the medication affects them.
Serious Warnings
- Black Box Warning: Dimehydrinate does not carry a specific Black Box Warning issued by the U.S. Food and Drug Administration (FDA). However, healthcare professionals and patients should be acutely aware of several **Serious Warnings** associated with its use, particularly concerning its potential for significant central nervous system (CNS) depression and pronounced anticholinergic effects. Users are strongly advised against engaging in activities requiring mental alertness, such as driving a motor vehicle or operating heavy machinery, until they ascertain how dimehydrinate affects their individual mental and physical faculties, as it can cause profound drowsiness, dizziness, and impaired coordination. Concurrent use with alcohol, benzodiazepines, opioids, or other CNS depressants is strictly cautioned against due to the additive sedative effects, which can lead to severe respiratory depression, prolonged sedation, coma, or potentially fatal outcomes. Extreme caution is paramount in elderly patients, who are at an increased risk for falls, confusion, cognitive impairment, and other anticholinergic adverse events like urinary retention and exacerbation of glaucoma. Pediatric patients may experience paradoxical excitation rather than sedation. Patients with pre-existing medical conditions such as asthma, narrow-angle glaucoma, prostatic hypertrophy, or urinary retention should use dimehydrinate only under strict medical supervision due to the heightened risk of worsening these conditions.
- Dimehydrinate may cause significant drowsiness and impair the mental and/or physical abilities required for the performance of hazardous tasks such as operating machinery or driving a motor vehicle.
- Concomitant use with alcohol or other central nervous system (CNS) depressants (e.
- g.
- , sedatives, hypnotics, tranquilizers, opioids) can potentiate these sedative effects, leading to profound impairment, increased risk of accidents, severe respiratory depression, coma, or even death.
- Caution is advised in patients with respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), or emphysema, as the anticholinergic drying effects may thicken bronchial secretions and impede airway clearance.
- Patients with narrow-angle glaucoma, prostatic hypertrophy, or conditions causing urinary retention or pyloroduodenal obstruction should use this medication with extreme caution due to its anticholinergic properties which can exacerbate these conditions.
- Pediatric patients, especially young children, may experience paradoxical excitation rather than sedation.
- Elderly individuals are particularly susceptible to anticholinergic adverse effects, including confusion, cognitive impairment, and increased risk of falls.
- Pregnant or breastfeeding individuals should consult a healthcare professional before use, as safety data in these populations are limited and its use should only be considered if the potential benefit outweighs the potential risk.
How it Works (Mechanism of Action)
Dimehydrinate is an antihistamine with significant anticholinergic properties, functioning primarily as a first-generation H1-receptor antagonist. It acts by competitively blocking histamine H1 receptors, particularly those located in the brainstem's chemoreceptor trigger zone (CTZ) and the vestibular apparatus. By stabilizing the labyrinthine function and decreasing the excitability of the vestibular system, it effectively reduces the neural signals that contribute to nausea, vomiting, and dizziness associated with motion. Furthermore, its anticholinergic effects, through antagonism of muscarinic receptors, contribute to its antiemetic and anti-vertigo properties by inhibiting cholinergic pathways involved in the emetic reflex and vestibular responses. This dual mechanism helps to suppress the neural impulses from the inner ear to the vomiting center in the medulla, thus preventing or alleviating symptoms of motion sickness and vertigo. It also exerts a mild sedative effect, further aiding symptom control.